Riskpilot← Back to searchSign inGet full accessDr EOS AB
ABActiveOrg 5593174674Vårmätaregatan 46Medical specialists activities · NACE 8622Est. 20211 employees
Revenue 2025
SEK 350K
-6% vs 2024
EBITDA margin
85.1%
-9% vs 2024
Equity ratio
73.5%
Financial strength
Net profit 2025
SEK 237K
-9% vs 2024
| Revenue | SEK 350K | -6% |
| EBITDA | SEK 298K | -9% |
| Net profit | SEK 237K | -9% |
| Total assets | SEK 401K | +0% |
| Equity | SEK 295K | +3% |
| Employees | 1 | — |
Legal name
Dr EOS AB
Org number
5593174674
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
14 maj 2021
Share capital
SEK 25 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-04-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Läkarkonsult inom allmänmedicin och onkologi. Sjukvård. Friskvård. Rådgivning, utbildning och föreläsning om hälsofrämjande livsstil, idrott, friskvård. Investering och samarbete med andra bolag inom idrott, vård, omsorg och farmakologisk inriktning.
Address
Vårmätaregatan 46
Email
dreos.ab@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | 270 | 304 | 373 | 350 |
| Staff expenses | — | −26 | −23 | −26 |
| EBITDA | 219 | 269 | 327 | 298 |
| Depreciation & amort. | −0 | — | — | — |
| EBIT | 219 | 269 | 327 | 298 |
| Net financials | — | −6 | 1 | 0 |
| Profit before tax | 219 | 263 | 328 | 298 |
| Tax | −46 | −54 | −67 | −61 |
| Net profit | 173 | 209 | 260 | 237 |
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 305 | 313 | 401 | 401 |
| Equity | 198 | 235 | 286 | 295 |
| Long-term debt | 0 | 0 | — | — |
| Short-term debt | 107 | 77 | 115 | 106 |
| Total debt | 107 | 77 | 115 | 106 |
EBITDA margin
85.1%
This company
15.8%
Market median
+439% vs market
20222025
Equity ratio
73.5%
This company
38.2%
Market median
+92% vs market
20222025
Return on equity
80.4%
This company
18.4%
Market median
+337% vs market
20222025
Net profit margin
67.7%
This company
8.1%
Market median
+736% vs market
20222025
Asset turnover
0.87×
This company
1.12×
Market median
+22% vs market
20222025
Debt / equity
0.36×
This company
0.62×
Market median
+42% vs market
20222025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-05-01 – 2025-04-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-05-01 – 2022-04-30
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Dr EOS AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Erzsébet K Szentkirályi Szekely | Board of Directors | 0 companies |
| Laszlo-Oliver Szekely | Deputy Board Member | 0 companies |